In parallel, in vitro studies using human induced pluripotent stem cell (hiPSC)-derived OPCs carrying fused in sarcoma (FUS) gene mutations demonstrate aberrant Ca2+ signaling, further implicating OPC dysfunction in the complex molecular mechanisms underlying ALS [132]. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.